SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    David J. Graham, Esther H. Zhou, Stephen McKean, Mark Levenson, Katlyn Calia, Kate Gelperin, Xiao Ding, Thomas E. MaCurdy, Chris Worrall, Jeffrey A. Kelman, Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers, Pharmacoepidemiology and Drug Safety, 2014, 23, 4
  2. 2
    David J. Graham, Kunthel By, Stephen McKean, Andrew Mosholder, Cynthia Kornegay, Judith A. Racoosin, Jessica Young, Mark Levenson, Thomas E. MaCurdy, Chris Worrall, Jeffrey A. Kelman, Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study, Pharmacoepidemiology and Drug Safety, 2014, 23, 9
  3. 3
    S. Cammarota, D. Bruzzese, A.L. Catapano, A. Citarella, L. De Luca, L. Manzoli, M. Masulli, E. Menditto, A. Mezzetti, S. Riegler, D. Putignano, E. Tragni, E. Novellino, G. Riccardi, Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy, Nutrition, Metabolism and Cardiovascular Diseases, 2014, 24, 1, 10

    CrossRef

  4. 4
    T. Hanatani, K. Sai, M. Tohkin, K. Segawa, M. Kimura, K. Hori, J. Kawakami, Y. Saito, An algorithm for the identification of heparin-induced thrombocytopenia using a medical information database, Journal of Clinical Pharmacy and Therapeutics, 2013, 38, 5
  5. 5
    David J. Graham, James R. Williams, Ya-Hui Hsueh, Katlyn Calia, Mark Levenson, Simone P. Pinheiro, Thomas E. MaCurdy, David Shih, Chris Worrall, Jeffrey A. Kelman, Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone, Movement Disorders, 2013, 28, 4
  6. 6
    Daniel H. Solomon, Jeffrey R. Curtis, Kenneth G. Saag, Joyce Lii, Lang Chen, Leslie R. Harrold, Lisa J. Herrinton, David J. Graham, Mary K. Kowal, Bindee Kuriya, Liyan Liu, Marie R. Griffin, James D. Lewis, Jeremy A. Rassen, Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs, The American Journal of Medicine, 2013, 126, 8, 730.e9

    CrossRef

  7. 7
    Carlos Vallarino, Alfonso Perez, Gregory Fusco, Huifang Liang, Morgan Bron, Sudhakar Manne, Guiandre Joseph, Shawn Yu, Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights, Clinical Drug Investigation, 2013, 33, 9, 621

    CrossRef

  8. 8
    Sarah L. Cutrona, Sengwee Toh, Aarthi Iyer, Sarah Foy, Gregory W. Daniel, Vinit P. Nair, Daniel Ng, Melissa G. Butler, Denise Boudreau, Susan Forrow, Robert Goldberg, Joel Gore, David McManus, Judith A. Racoosin, Jerry H. Gurwitz, Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program, Pharmacoepidemiology and Drug Safety, 2013, 22, 1
  9. 9
    Kurt Niesner, Harvey J. Murff, Marie R. Griffin, Brian Wasserman, Robert Greevy, Carlos G. Grijalva, Christianne L. Roumie, Validation of VA Administrative Data Algorithms for Identifying Cardiovascular Disease Hospitalization, Epidemiology, 2013, 24, 2, 334

    CrossRef

  10. You have free access to this content10
    Sarah L. Cutrona, Sengwee Toh, Aarthi Iyer, Sarah Foy, Elizabeth Cavagnaro, Susan Forrow, Judith A. Racoosin, Robert Goldberg, Jerry H. Gurwitz, Design for validation of acute myocardial infarction cases in Mini-Sentinel, Pharmacoepidemiology and Drug Safety, 2012, 21,
  11. 11
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 3